Explore News
-
Why GSK is Acquiring Nuvalent for $10.6 Billion
GSK’s acquisition of Nuvalent marks a significant move in the pharma industry
-
Gene-Editing Tech Surges Forward with 90% Success Rate
Scientists achieve promising results with improved CRISPR technique, but major hurdles persist
-
Why Top AI CEOs Are Warning about Biological Weapons
A joint open letter signed by top AI executives urges Congress to require safeguards for…
-
Abivax Stock Plunges 32% After Bowel Disease Drug Trial Update
Abivax’s stock plummeted after disappointing trial data
-
China Surges in Drug Development, Threatening US Dominance
China’s growing biotech industry sparks concern over US leadership
-
Biotech Barbie Cathy Tie Reveals Mission to Genetically Modify Babies
Cathy Tie’s mission to genetically modify babies sparks controversy and debate
-
Eli Lilly Surges into Infectious Disease Market with $4 Billion Deals
Eli Lilly expands into infectious disease research with significant investments
-
Lab-Grown Sperm Breaks Infertility Barrier for Azoospermic Men
A pioneering biotech startup claims to have grown functional sperm from infertile men, potentially unlocking…
-
Why Is a Biotech Billionaire Promoting PEDs in Sports?
Christian Angermayer, a German billionaire with stakes in biotech and psychedelics, is launching the Enhanced…
-
How Quantum Physics and AI Are Reshaping Enzyme Design
UK-based Imperagen emerges from stealth with £5 million in seed funding to pioneer a new…
